Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: A case-control study

Infection, Genetics and Evolution

Volumn 3, Issue 3, 2003, Pages 183-188

  Sharma, S K ^a   Turaga, K K ^a   Balamurugan, A ^a   Saha, P K ^a   Pandey, R M ^a   Jain, N K ^b   Katoch, V M ^c   Mehra, N K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b New Delhi Tuberculosis Centre   (India)

^c Central Jalma Research Institute for Leprosy   (India)

Author keywords

Clinical predictors; Human leukocyte antigen (HLA); Immunogenetic predictors; Multi drug resistant tuberculosis

Indexed keywords

ETHAMBUTOL; GENOMIC DNA; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; ISONIAZID; PRIMER DNA; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ALLELE; ARTICLE; BIOTINYLATION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; PATIENT CARE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; THORAX RADIOGRAPHY;

ADULT; BODY WEIGHT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INDIA; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; RISK FACTORS; SOCIAL CLASS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0141716998     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-1348(03)00086-8     Document Type: Article

References (28)

1. Alland D. Kalkut G.E. Moss A.R. McAdam R.A. Hahn J.A. Bosworth W. Drucker E. Bloom B.R. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods N. Engl. J. Med. 330 1994 1710-1716
2. Bellamy R. Ruwende C. Corrah T. McAdam K.P.W.J. Whittle C.H. Hill A.V.S. Variants in the NRAMP1 gene and susceptibility to tuberculosis in West Africans N. Engl. J. Med. 338 1998 640-644
3. Bothamley G.H. Beck J.S. Schreuder G.M.T. D'Amaro J. deVries R.R.P. Kardjito T. Ivanyi J. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA J. Infect. Dis. 159 1989 549-555
4. Brahmajothi V. Pitchappan R.M. Kakkanaiah V.N. Sashidhar M. Rajaram K. Ramu S. Palanimurugan K. Paramasivam C.N. Prabhakar R. Association of pulmonary tuberculosis and HLA in South India Tubercle 72 1991 123-132
5. Brudney K. Doblin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programs Am. Rev. Respir. Dis. 144 1991 745-749
6. Canetti G. Fox W. Khomenko A. Mahler H.T. Menon N.K. Mitchison D.A. Rist N. Smelev N.A. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes Bull. World Health Organ. 41 1969 21-43
7. Dubaniewicz A. Lewko B. Moszkowska G. Zamorska B. Stepinski J. Molecular subtypes of the HLA-DR antigens in pulmonary tuberculosis Int. J. Infect. Dis. 4 2000 129-133
8. Espinal M.A. Laszlo A. Simonsen L. Boulahbal F. Kim S.J. Reniero A. Hoffner S. Rieder H.L. Binkin N. Dye C. Williams R. Raviglione M.C. World Health Organization, International Union against Tuberculosis and Lung Disease Working Group on antituberculosis drug resistance surveillance. Global trends in resistance to antituberculosis drugs N. Engl. J. Med. 344 2001 1294-1303
9. Frieden T.R. Sterling T. Pablos-Mendez A. Kilburn J.O. Cauthen G.M. Dooley S.W. The emergence of drug-resistant tuberculosis in New York City N. Engl. J. Med. 328 1993 521-526
10. Garcia-Garcia M.L. Jimenez Corona M.E. Ponce-de-Leon A. Jimenez-Corona A. Palacios-Martinez M. Balandrano-Campos S. Ferreyra-Reyes L. Juarez-Sandino L. Sifuentes-Osornio J. Olivera-Diaz H. Valdespino-Gomez J.L. Small P.M. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico Int. J. Tuberc. Lung Dis. 4 2000 S168-170
11. Harrow E.M. Rangel J.M. Arriega J.M. Cohen I. Regil Ruiz M.I. DeRiemer K. Small P.M. Epidemiology and clinical consequences of drug-resistant tuberculosis in a Guatemalan hospital Chest 113 1998 1452-1458
12. Khomenko A.G. Litvinov V.I. Chukanova V.P. Pospelov L.E. Tuberculosis in patients with various HLA phenotypes Tubercle 71 1990 187-192
13. Mehra, N.K., Taneja, V., Chaudhri, T.K., Kailash, S., Bin, A.J., Chang, S.X., Hawkins, B.R., Pitchappan, R.M., 1986. Pulmonary tuberculosis. In: Aizawa, M. (Ed.), HLA in Asia-Oceania-1986. Hokkaido University Press, Japan, pp. 374-379.
14. Mendoza M.T. Gonzanga A.J. Roa C. Velmonte M.A. Jorge M. Montoya J.C. Tan Torres T. Ong M. Barez M.Y. Ang C.F. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines Int. J. Tuberc. Lung Dis. 1 1997 59-63
15. National Tuberculosis Association of the USA, 1961. Diagnostic standards and classification of tuberculosis. National Tuberculosis Association, New York.
16. Pablos-Mendez A. Raviglione M.C. Laszlo A. Binkin N. Rieder H.L. Bustreo F. Cohn D.L. Lambregts-van Weezenbeek C.S. Kim S.J. Chaulet P. Nunn P. Global surveillance for antituberculosis drug resistance, 1994-1997 N. Engl. J. Med. 338 1998 1641-1649
17. Park M. Song E. Park H. Kwon S. Han S. Shim Y. HLA-DRB1 and DQB1 gene polymorphism is associated with multidrug-resistant tuberculosis in Korean patients Hum. Immunol. 63 2002 S33
18. Rajalingam R. Mehra N.K. Jain R.C. Myneedu J.N. Polymerase chain reaction-based sequence specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity J. Infect. Dis. 173 1996 669-676
19. Shafer R.W. Small P.M. Larkin C. Small P.M. Temporal trends and transmission patterns during the emergence of multi-drug resistant tuberculosis in New York City: a molecular epidemiolgic assessment J. Infect. Dis. 171 1995 170-176
20. Sharma S.K. Saha P.K. Dixit Y. Naveen S.H. Seth P. Pande J.N. HIV seropositivity in tuberculosis patients Indian J. Chest Dis. Allied Sci. 42 2000 152-160
21. Singh S.P.N. Mehra N.K. Dingley H.B. Pande J.N. Vaidya M.C. HLA-A, -B, -C, and -DR antigen profile in pulmonary tuberculosis in North India Tissue Antigens 21 1983 380-384
22. Small P.M. Hopewell P.C. Singh S.P. Paz A. Parsonnet J. Ruston D.C. Schecter G.F. Daley C.L. Schoolnik G.K. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods N. Engl. J. Med. 330 1994 1703-1709
23. Takahashi M. Ishizaka A. Nakamura H. Kobayashi K. Nakamura M. Namiki M. Sekita T. Okajima S. Specific HLA in pulmonary MAC infection in a Japanese population Am. J. Respir. Crit. Care Med. 162 2000 316-318
24. Telzak E.E. Chirgwin K.D. Nelson E.T. Matts J.P. Sepkowitz K.A. Benson C.A. Perlman D.C. El-Sadr W.M. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health Int. J. Tuberc. Lung Dis. 3 1999 337-343
25. Teran-Escandon D. Teran-Ortiz L. Gonzalez-Avila G. Vaca-Marin M.A. Granados J. Human leukocyte antigen associated susceptibility to pulmonary tuberculosis. Molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients Chest 115 1999 428-433
26. Weltman A.C. Rose D.N. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital Arch. Intern. Med. 154 1994 2161-2167
27. World Health Organization, 1997. Antituberculosis drug resistance in the world: the WHO/IUATLD Global project on antituberculosis drug resistance surveillance, 1994-1997. WHO Global Tuberculosis Programme, Geneva, Switzerland; Report No.: WHO/TB/97.229.
28. World Health Organization, 1999. Global Tuberculosis Control: WHO report. World Health Organization, Geneva, Switzerland; Report No: WHO/CDS/CPC/TB/99.529.